Royal Bank of Canada’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-500
Closed -$59K 6806
2019
Q2
$59K Buy
+500
New +$50.4K ﹤0.01% 5179
2019
Q1
Sell
-100
Closed -$6K 6888
2018
Q4
$6K Buy
+100
New +$6.86K ﹤0.01% 6096
2014
Q2
Sell
-14,000
Closed -$198K 5982
2014
Q1
$198K Buy
+14,000
New +$189K ﹤0.01% 4119

Other funds holding EXAS

Royal Bank of Canada's EXAS Position: Q1 2026 in Review

Royal Bank of Canada sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 82,548 shares — an estimated $8.38M sold.

Royal Bank of Canada first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $18.8M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Royal Bank of Canada reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 82,548 Exact Sciences shares in Q1 2026, an estimated $8.38M.
  • Royal Bank of Canada first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Royal Bank of Canada's Exact Sciences position peaked at $18.8M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.